Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drug usage guidelines, Part 2: Analysis of program outcome.

R A Patry, S L Huber, H D Hudson

    Hospital Formulary
    |December 11, 1984
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    PRELIMINARY REPORT ON A CASE OF TULARAEMIA.

    Canadian Medical Association journal·2010
    Same author

    Achieving best practices in health-system pharmacy: eliminating the 'practice gap'.

    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·2000
    Same author

    The consequences of diarrhea occurring during chemotherapy for colorectal cancer: a retrospective study.

    The oncologist·2000
    Same author

    The rapid assessment of fatigue severity in cancer patients: use of the Brief Fatigue Inventory.

    Cancer·1999
    Same author

    Comment: cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.

    The Annals of pharmacotherapy·1997
    Same author

    Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia.

    Annals of internal medicine·1996

    Integrating a Drug Usage Guidelines (DUG) program into hospital formulary systems significantly altered drug review processes. Adherence to DUG protocols, including clinical data submission, is crucial for successful drug additions and formulary management.

    Area of Science:

    • Health Sciences
    • Pharmacy Practice
    • Hospital Administration

    Background:

    • Hospital formulary systems are critical for managing medication use and costs.
    • Drug selection processes often face challenges with new product submissions.
    • A structured Drug Usage Guidelines (DUG) program can optimize formulary management.

    Purpose of the Study:

    • To evaluate the impact of integrating a Drug Usage Guidelines (DUG) program with a hospital formulary system.
    • To assess changes in P & T Committee submissions and formulary additions post-DUG implementation.
    • To identify factors influencing the success of DUG program integration.

    Main Methods:

    • Analysis of formulary data before and after DUG program implementation.
    • Review of P & T Committee submission logs and drug addition rates.

    Related Experiment Videos

  • Assessment of adherence to DUG submission protocols, including clinical data requirements.

    • Main Results:

    • Significant changes observed in the number of requests submitted to the P & T Committee.
    • Notable alterations in the number of drugs added to the hospital formulary.
    • Delayed consideration and withdrawal of drugs due to non-compliance with DUG protocols, especially regarding clinical data.

    Conclusions:

    • Integration of a DUG program significantly impacts hospital formulary management.
    • Strict adherence to DUG protocols, including evidence-based data, is essential for drug approval.
    • Early physician involvement is a key factor for the sustained success of DUG programs.